Mangieri A, Montalto C, Pagnesi M, et al. Mechanism and implications of the tricuspid regurgitation. Circ Cardiovasc Interv [Internet]. 2017 [cited 2023 Sep 5]; Available from: https://www.ahajournals.org/doi/abs/10.1161/CIRCINTERVENTIONS.117.005043

Badano LP, Muraru D, Enriquez-Sarano M. Assessment of functional tricuspid regurgitation. Eur Heart J. 2013 Jul;34(25):1875–85.

Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004 Feb 4;43(3):405–9.

Taramasso M, Vanermen H, Maisano F, Guidotti A, La Canna G, Alfieri O. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol. 2012 Feb 21;59(8):703–10.

Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017 Dec 19;70(24):2953–60.

Abdul-Jawad Altisent O, Benetis R, Rumbinaite E, et al. Caval valve implantation (CAVI): An emerging therapy for treating severe tricuspid regurgitation. J Clin Med Res [Internet]. 2021 Oct 7;10(19). Available from: http://dx.doi.org/10.3390/jcm10194601

Dreyfus J, Flagiello M, Bazire B, et al. Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. Eur Heart J. 2020 Sep 25;41(45):4304–17.

Mulla S, Asuka E, Bora V, Siddiqui WJ. Tricuspid regurgitation. StatPearls Publishing; 2022.

Baratto C, Caravita S, Corbetta G, et al. Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction. Front Cardiovasc Med. 2023 Mar 1;10:1061118.

Henning RJ. Tricuspid valve regurgitation: current diagnosis and treatment. Am J Cardiovasc Dis. 2022 Feb 15;12(1):1–18.

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e35–71.

Besler’ [’christian, Seeburger’ ’joerg, Thiele’ ’holger, Lurz’] ’philipp. Treatment options for severe functional tricuspid regurgitation: indications, techniques and current challenges [Internet]. [cited 2023 Sep 11]. Available from: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-16/Treatment-options-for-severe-functional-tricuspid-regurgitation-indications-techniques-and-current-challenges

Kültürsay B, Bingöl G, Güven B, Yıldız A, Ökçün B. TricValve pop-out: Management of transcatheter caval valve migration. Anatol J Cardiol. 2022 May;26(5):414–8.

Estévez-Loureiro R, Sánchez-Recalde A, Amat-Santos IJ, et al. 6-month outcomes of the TricValve system in patients with tricuspid regurgitation: The TRICUS EURO study. JACC Cardiovasc Interv. 2022 Jul 11;15(13):1366–77.

Case Medical Research. TRICUS STUDY euro - safety and efficacy of the TricValve® device. Case Medical Research [Internet]. 2019 Oct 28; Available from: https://ichgcp.net/clinical-trials-registry/NCT03723239

Papazoglou AS, Moysidis DV, Kartas A, et al. Oral anticoagulation challenges and therapeutic dilemmas in the very elderly: to treat and how to treat octogenarians and nonagenarians? Pol Arch Intern Med. 2023; 133: 16508. doi:10.20452/pamw.16508